Home › Funds › CVS HEALTH Corp › VGIT
CVS HEALTH Corp position in VGIT
VANGUARD INTERMEDIATE
CVS HEALTH Corp reported holding 85,000 shares of VGIT (VANGUARD INTERMEDIATE) in its Q3 2026 13F filing — a position valued at US$4.8M, representing 1.12% of its reported portfolio and ranking #20 among its reported holdings. CVS HEALTH Corp has disclosed VGIT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CVS HEALTH Corp's VGIT position evolved
CVS HEALTH Corp first disclosed a stake in VGIT in Q1 2026 at 85,000 shares (US$5.1M). Across 3 filings, CVS HEALTH Corp held the position steady without any share-count change. The most recent filing (Q3 2026) shows 85,000 shares valued at US$4.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 85.00K | $5.06M | New |
| Q2 2026 | 85.00K | $5.01M | Hold |
| Q3 2026 | 85.00K | $4.82M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VGIT and 13F data
VGIT (VANGUARD INTERMEDIATE) is a company whose sector is not yet classified in our data. 32 other funds we track also report a position in VGIT — the largest reported positions include Empower Advisory Group, LLC (US$1.51B), Creative Planning (US$1.29B), SCS Capital Management LLC (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VGIT
- Empower Advisory Group, LLC 25.56M sh · $1.51B · Q2 2026
- Creative Planning 22.73M sh · $1.29B · Q3 2026
- SCS Capital Management LLC 21.43M sh · $1.21B · Q3 2026
- Focus Partners Wealth 15.86M sh · $898.85M · Q3 2026
- UBS Group AG 14.84M sh · $841.11M · Q3 2026
- Employees Retirement System of Texas 12.86M sh · $728.76M · Q3 2026
- Focus Partners Advisor Solutions, LLC 10.40M sh · $589.37M · Q3 2026
- NEPC LLC 8.48M sh · $499.90M · Q2 2026
- MASECO LLP 7.21M sh · $408.69M · Q3 2026
- CAMBRIDGE ASSOCIATES LLC /MA/ /ADV 6.33M sh · $373.51M · Q2 2026
- Blue Trust, Inc. 6.59M sh · $373.46M · Q3 2026
- Savant Capital, LLC 5.52M sh · $313.02M · Q3 2026
More on CVS HEALTH Corp
FAQ
How long has CVS HEALTH Corp held VGIT?
CVS HEALTH Corp has disclosed VGIT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is CVS HEALTH Corp's current position in VGIT?
As of Q3 2026, CVS HEALTH Corp holds 85.00K shares of VGIT (VANGUARD INTERMEDIATE), valued at $4.82M, representing 1.12% of its reported portfolio and ranking #20.
Has CVS HEALTH Corp been buying or selling VGIT?
In the latest 13F filing (Q3 2026), CVS HEALTH Corp held unchanged its position in VGIT.
Which other funds hold VGIT?
Other major institutional holders of VGIT include Empower Advisory Group, LLC, Creative Planning, SCS Capital Management LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.